カテゴリ： 世界, 医療/バイオ, Market Monitor Global

医療用エリスロポエチン注射剤のグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他

■ 英語タイトル：Medical Erythropoietin Injection Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14416）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14416
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医療用エリスロポエチン注射剤のグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の医療用エリスロポエチン注射剤市場規模と予測を収録しています。・世界の医療用エリスロポエチン注射剤市場：売上、2018年-2023年、2024年-2029年
・世界の医療用エリスロポエチン注射剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用エリスロポエチン注射剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「エポエチンアルファ」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医療用エリスロポエチン注射剤のグローバル主要企業は、Amgen、 Johnson & Johnson、 Roche、 Kyowa Kirin、 LG Chem、 Daewoong Pharmaceutical、 Wockhardt、 CJ Healthcare、 3SBio、 Kexing Biopharm、 Harbin Pharmaceutical Group、 Beijing Four Rings Bio-Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医療用エリスロポエチン注射剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医療用エリスロポエチン注射剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の医療用エリスロポエチン注射剤市場：タイプ別市場シェア、2022年
・エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他

世界の医療用エリスロポエチン注射剤市場：用途別、2018年-2023年、2024年-2029年
世界の医療用エリスロポエチン注射剤市場：用途別市場シェア、2022年
・貧血、腎臓疾患、その他

世界の医療用エリスロポエチン注射剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の医療用エリスロポエチン注射剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医療用エリスロポエチン注射剤のグローバル売上、2018年-2023年
・主要企業における医療用エリスロポエチン注射剤のグローバル売上シェア、2022年
・主要企業における医療用エリスロポエチン注射剤のグローバル販売量、2018年-2023年
・主要企業における医療用エリスロポエチン注射剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Amgen、 Johnson & Johnson、 Roche、 Kyowa Kirin、 LG Chem、 Daewoong Pharmaceutical、 Wockhardt、 CJ Healthcare、 3SBio、 Kexing Biopharm、 Harbin Pharmaceutical Group、 Beijing Four Rings Bio-Pharmaceutical

*************************************************************

・調査・分析レポートの概要
医療用エリスロポエチン注射剤市場の定義
市場セグメント
世界の医療用エリスロポエチン注射剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用エリスロポエチン注射剤市場規模
世界の医療用エリスロポエチン注射剤市場規模：2022年 VS 2029年
世界の医療用エリスロポエチン注射剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用エリスロポエチン注射剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用エリスロポエチン注射剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他
医療用エリスロポエチン注射剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：貧血、腎臓疾患、その他
医療用エリスロポエチン注射剤の用途別グローバル売上・予測

・地域別市場分析
地域別医療用エリスロポエチン注射剤市場規模 2022年と2029年
地域別医療用エリスロポエチン注射剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen、 Johnson & Johnson、 Roche、 Kyowa Kirin、 LG Chem、 Daewoong Pharmaceutical、 Wockhardt、 CJ Healthcare、 3SBio、 Kexing Biopharm、 Harbin Pharmaceutical Group、 Beijing Four Rings Bio-Pharmaceutical
...

This research report provides a comprehensive analysis of the Medical Erythropoietin Injection market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Medical Erythropoietin Injection market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Medical Erythropoietin Injection, challenges faced by the industry, and potential opportunities for market players.
The global Medical Erythropoietin Injection market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Medical Erythropoietin Injection market presents opportunities for various stakeholders, including Anemia, Kidney Disorders. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Medical Erythropoietin Injection market. Additionally, the growing consumer demand present avenues for market expansion.
The global Medical Erythropoietin Injection market was valued at US$ 8647.1 million in 2022 and is projected to reach US$ 13290 million by 2029, at a CAGR of 6.5% during the forecast period.
The Medical Erythropoietin Injection, used for treating anemia, is widely employed in conditions such as chronic kidney disease, cancer chemotherapy, and other anemia-inducing diseases. The market for this product is substantial, with promising sales prospects driven by an aging population and an increasing number of patients with chronic illnesses. Future developments may involve innovations in treatment approaches and manufacturing techniques to enhance the drug’s efficacy and safety.
Key Features:
The research report on the Medical Erythropoietin Injection market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Medical Erythropoietin Injection market.
Market Overview: The report provides a comprehensive overview of the Medical Erythropoietin Injection market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Epoetin-alfa, Epoetin-beta), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Medical Erythropoietin Injection market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Medical Erythropoietin Injection market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Medical Erythropoietin Injection market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Medical Erythropoietin Injection market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Medical Erythropoietin Injection market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Medical Erythropoietin Injection market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Medical Erythropoietin Injection, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Medical Erythropoietin Injection market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Medical Erythropoietin Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others
Market segment by Application
Anemia
Kidney Disorders
Others
Global Medical Erythropoietin Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Erythropoietin Injection, market overview.
Chapter 2: Global Medical Erythropoietin Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Erythropoietin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Erythropoietin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Erythropoietin Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Medical Erythropoietin Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Erythropoietin Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Erythropoietin Injection Overall Market Size
2.1 Global Medical Erythropoietin Injection Market Size: 2022 VS 2029
2.2 Global Medical Erythropoietin Injection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Erythropoietin Injection Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Erythropoietin Injection Players in Global Market
3.2 Top Global Medical Erythropoietin Injection Companies Ranked by Revenue
3.3 Global Medical Erythropoietin Injection Revenue by Companies
3.4 Global Medical Erythropoietin Injection Sales by Companies
3.5 Global Medical Erythropoietin Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Erythropoietin Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Erythropoietin Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Erythropoietin Injection Players in Global Market
3.8.1 List of Global Tier 1 Medical Erythropoietin Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Erythropoietin Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Erythropoietin Injection Market Size Markets, 2022 & 2029
4.1.2 Epoetin-alfa
4.1.3 Epoetin-beta
4.1.4 Darbepoetin-alfa
4.1.5 Others
4.2 By Type – Global Medical Erythropoietin Injection Revenue & Forecasts
4.2.1 By Type – Global Medical Erythropoietin Injection Revenue, 2018-2023
4.2.2 By Type – Global Medical Erythropoietin Injection Revenue, 2024-2029
4.2.3 By Type – Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Erythropoietin Injection Sales & Forecasts
4.3.1 By Type – Global Medical Erythropoietin Injection Sales, 2018-2023
4.3.2 By Type – Global Medical Erythropoietin Injection Sales, 2024-2029
4.3.3 By Type – Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
4.4 By Type – Global Medical Erythropoietin Injection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Erythropoietin Injection Market Size, 2022 & 2029
5.1.2 Anemia
5.1.3 Kidney Disorders
5.1.4 Others
5.2 By Application – Global Medical Erythropoietin Injection Revenue & Forecasts
5.2.1 By Application – Global Medical Erythropoietin Injection Revenue, 2018-2023
5.2.2 By Application – Global Medical Erythropoietin Injection Revenue, 2024-2029
5.2.3 By Application – Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Erythropoietin Injection Sales & Forecasts
5.3.1 By Application – Global Medical Erythropoietin Injection Sales, 2018-2023
5.3.2 By Application – Global Medical Erythropoietin Injection Sales, 2024-2029
5.3.3 By Application – Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
5.4 By Application – Global Medical Erythropoietin Injection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Erythropoietin Injection Market Size, 2022 & 2029
6.2 By Region – Global Medical Erythropoietin Injection Revenue & Forecasts
6.2.1 By Region – Global Medical Erythropoietin Injection Revenue, 2018-2023
6.2.2 By Region – Global Medical Erythropoietin Injection Revenue, 2024-2029
6.2.3 By Region – Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Erythropoietin Injection Sales & Forecasts
6.3.1 By Region – Global Medical Erythropoietin Injection Sales, 2018-2023
6.3.2 By Region – Global Medical Erythropoietin Injection Sales, 2024-2029
6.3.3 By Region – Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Erythropoietin Injection Revenue, 2018-2029
6.4.2 By Country – North America Medical Erythropoietin Injection Sales, 2018-2029
6.4.3 US Medical Erythropoietin Injection Market Size, 2018-2029
6.4.4 Canada Medical Erythropoietin Injection Market Size, 2018-2029
6.4.5 Mexico Medical Erythropoietin Injection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Erythropoietin Injection Revenue, 2018-2029
6.5.2 By Country – Europe Medical Erythropoietin Injection Sales, 2018-2029
6.5.3 Germany Medical Erythropoietin Injection Market Size, 2018-2029
6.5.4 France Medical Erythropoietin Injection Market Size, 2018-2029
6.5.5 U.K. Medical Erythropoietin Injection Market Size, 2018-2029
6.5.6 Italy Medical Erythropoietin Injection Market Size, 2018-2029
6.5.7 Russia Medical Erythropoietin Injection Market Size, 2018-2029
6.5.8 Nordic Countries Medical Erythropoietin Injection Market Size, 2018-2029
6.5.9 Benelux Medical Erythropoietin Injection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Erythropoietin Injection Revenue, 2018-2029
6.6.2 By Region – Asia Medical Erythropoietin Injection Sales, 2018-2029
6.6.3 China Medical Erythropoietin Injection Market Size, 2018-2029
6.6.4 Japan Medical Erythropoietin Injection Market Size, 2018-2029
6.6.5 South Korea Medical Erythropoietin Injection Market Size, 2018-2029
6.6.6 Southeast Asia Medical Erythropoietin Injection Market Size, 2018-2029
6.6.7 India Medical Erythropoietin Injection Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Erythropoietin Injection Revenue, 2018-2029
6.7.2 By Country – South America Medical Erythropoietin Injection Sales, 2018-2029
6.7.3 Brazil Medical Erythropoietin Injection Market Size, 2018-2029
6.7.4 Argentina Medical Erythropoietin Injection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Erythropoietin Injection Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Erythropoietin Injection Sales, 2018-2029
6.8.3 Turkey Medical Erythropoietin Injection Market Size, 2018-2029
6.8.4 Israel Medical Erythropoietin Injection Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Erythropoietin Injection Market Size, 2018-2029
6.8.6 UAE Medical Erythropoietin Injection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Medical Erythropoietin Injection Major Product Offerings
7.1.4 Amgen Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Medical Erythropoietin Injection Major Product Offerings
7.2.4 Johnson & Johnson Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Medical Erythropoietin Injection Major Product Offerings
7.3.4 Roche Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Kyowa Kirin
7.4.1 Kyowa Kirin Company Summary
7.4.2 Kyowa Kirin Business Overview
7.4.3 Kyowa Kirin Medical Erythropoietin Injection Major Product Offerings
7.4.4 Kyowa Kirin Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.4.5 Kyowa Kirin Key News & Latest Developments
7.5 LG Chem
7.5.1 LG Chem Company Summary
7.5.2 LG Chem Business Overview
7.5.3 LG Chem Medical Erythropoietin Injection Major Product Offerings
7.5.4 LG Chem Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.5.5 LG Chem Key News & Latest Developments
7.6 Daewoong Pharmaceutical
7.6.1 Daewoong Pharmaceutical Company Summary
7.6.2 Daewoong Pharmaceutical Business Overview
7.6.3 Daewoong Pharmaceutical Medical Erythropoietin Injection Major Product Offerings
7.6.4 Daewoong Pharmaceutical Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.6.5 Daewoong Pharmaceutical Key News & Latest Developments
7.7 Wockhardt
7.7.1 Wockhardt Company Summary
7.7.2 Wockhardt Business Overview
7.7.3 Wockhardt Medical Erythropoietin Injection Major Product Offerings
7.7.4 Wockhardt Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.7.5 Wockhardt Key News & Latest Developments
7.8 CJ Healthcare
7.8.1 CJ Healthcare Company Summary
7.8.2 CJ Healthcare Business Overview
7.8.3 CJ Healthcare Medical Erythropoietin Injection Major Product Offerings
7.8.4 CJ Healthcare Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.8.5 CJ Healthcare Key News & Latest Developments
7.9 3SBio
7.9.1 3SBio Company Summary
7.9.2 3SBio Business Overview
7.9.3 3SBio Medical Erythropoietin Injection Major Product Offerings
7.9.4 3SBio Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.9.5 3SBio Key News & Latest Developments
7.10 Kexing Biopharm
7.10.1 Kexing Biopharm Company Summary
7.10.2 Kexing Biopharm Business Overview
7.10.3 Kexing Biopharm Medical Erythropoietin Injection Major Product Offerings
7.10.4 Kexing Biopharm Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.10.5 Kexing Biopharm Key News & Latest Developments
7.11 Harbin Pharmaceutical Group
7.11.1 Harbin Pharmaceutical Group Company Summary
7.11.2 Harbin Pharmaceutical Group Business Overview
7.11.3 Harbin Pharmaceutical Group Medical Erythropoietin Injection Major Product Offerings
7.11.4 Harbin Pharmaceutical Group Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.11.5 Harbin Pharmaceutical Group Key News & Latest Developments
7.12 Beijing Four Rings Bio-Pharmaceutical
7.12.1 Beijing Four Rings Bio-Pharmaceutical Company Summary
7.12.2 Beijing Four Rings Bio-Pharmaceutical Business Overview
7.12.3 Beijing Four Rings Bio-Pharmaceutical Medical Erythropoietin Injection Major Product Offerings
7.12.4 Beijing Four Rings Bio-Pharmaceutical Medical Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.12.5 Beijing Four Rings Bio-Pharmaceutical Key News & Latest Developments
8 Global Medical Erythropoietin Injection Production Capacity, Analysis
8.1 Global Medical Erythropoietin Injection Production Capacity, 2018-2029
8.2 Medical Erythropoietin Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Erythropoietin Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Erythropoietin Injection Supply Chain Analysis
10.1 Medical Erythropoietin Injection Industry Value Chain
10.2 Medical Erythropoietin Injection Upstream Market
10.3 Medical Erythropoietin Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Erythropoietin Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Medical Erythropoietin Injection in Global Market
Table 2. Top Medical Erythropoietin Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Medical Erythropoietin Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Medical Erythropoietin Injection Revenue Share by Companies, 2018-2023
Table 5. Global Medical Erythropoietin Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Medical Erythropoietin Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Medical Erythropoietin Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Medical Erythropoietin Injection Product Type
Table 9. List of Global Tier 1 Medical Erythropoietin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medical Erythropoietin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Medical Erythropoietin Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Medical Erythropoietin Injection Sales (K Units), 2024-2029
Table 16. By Application – Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Medical Erythropoietin Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Medical Erythropoietin Injection Sales (K Units), 2024-2029
Table 21. By Region – Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Medical Erythropoietin Injection Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Medical Erythropoietin Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Medical Erythropoietin Injection Sales (K Units), 2024-2029
Table 26. By Country - North America Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Medical Erythropoietin Injection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Medical Erythropoietin Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Medical Erythropoietin Injection Sales, (K Units), 2024-2029
Table 30. By Country - Europe Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Medical Erythropoietin Injection Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Medical Erythropoietin Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Medical Erythropoietin Injection Sales, (K Units), 2024-2029
Table 34. By Region - Asia Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Medical Erythropoietin Injection Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Medical Erythropoietin Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Medical Erythropoietin Injection Sales, (K Units), 2024-2029
Table 38. By Country - South America Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Medical Erythropoietin Injection Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Medical Erythropoietin Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Medical Erythropoietin Injection Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Medical Erythropoietin Injection Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Medical Erythropoietin Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Medical Erythropoietin Injection Sales, (K Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Medical Erythropoietin Injection Product Offerings
Table 48. Amgen Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Medical Erythropoietin Injection Product Offerings
Table 52. Johnson & Johnson Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Medical Erythropoietin Injection Product Offerings
Table 56. Roche Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Kyowa Kirin Company Summary
Table 59. Kyowa Kirin Medical Erythropoietin Injection Product Offerings
Table 60. Kyowa Kirin Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Kyowa Kirin Key News & Latest Developments
Table 62. LG Chem Company Summary
Table 63. LG Chem Medical Erythropoietin Injection Product Offerings
Table 64. LG Chem Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. LG Chem Key News & Latest Developments
Table 66. Daewoong Pharmaceutical Company Summary
Table 67. Daewoong Pharmaceutical Medical Erythropoietin Injection Product Offerings
Table 68. Daewoong Pharmaceutical Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Daewoong Pharmaceutical Key News & Latest Developments
Table 70. Wockhardt Company Summary
Table 71. Wockhardt Medical Erythropoietin Injection Product Offerings
Table 72. Wockhardt Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Wockhardt Key News & Latest Developments
Table 74. CJ Healthcare Company Summary
Table 75. CJ Healthcare Medical Erythropoietin Injection Product Offerings
Table 76. CJ Healthcare Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. CJ Healthcare Key News & Latest Developments
Table 78. 3SBio Company Summary
Table 79. 3SBio Medical Erythropoietin Injection Product Offerings
Table 80. 3SBio Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. 3SBio Key News & Latest Developments
Table 82. Kexing Biopharm Company Summary
Table 83. Kexing Biopharm Medical Erythropoietin Injection Product Offerings
Table 84. Kexing Biopharm Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Kexing Biopharm Key News & Latest Developments
Table 86. Harbin Pharmaceutical Group Company Summary
Table 87. Harbin Pharmaceutical Group Medical Erythropoietin Injection Product Offerings
Table 88. Harbin Pharmaceutical Group Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Harbin Pharmaceutical Group Key News & Latest Developments
Table 90. Beijing Four Rings Bio-Pharmaceutical Company Summary
Table 91. Beijing Four Rings Bio-Pharmaceutical Medical Erythropoietin Injection Product Offerings
Table 92. Beijing Four Rings Bio-Pharmaceutical Medical Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Beijing Four Rings Bio-Pharmaceutical Key News & Latest Developments
Table 94. Medical Erythropoietin Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 95. Global Medical Erythropoietin Injection Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Medical Erythropoietin Injection Production by Region, 2018-2023 (K Units)
Table 97. Global Medical Erythropoietin Injection Production by Region, 2024-2029 (K Units)
Table 98. Medical Erythropoietin Injection Market Opportunities & Trends in Global Market
Table 99. Medical Erythropoietin Injection Market Drivers in Global Market
Table 100. Medical Erythropoietin Injection Market Restraints in Global Market
Table 101. Medical Erythropoietin Injection Raw Materials
Table 102. Medical Erythropoietin Injection Raw Materials Suppliers in Global Market
Table 103. Typical Medical Erythropoietin Injection Downstream
Table 104. Medical Erythropoietin Injection Downstream Clients in Global Market
Table 105. Medical Erythropoietin Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medical Erythropoietin Injection Segment by Type in 2022
Figure 2. Medical Erythropoietin Injection Segment by Application in 2022
Figure 3. Global Medical Erythropoietin Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Medical Erythropoietin Injection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Medical Erythropoietin Injection Revenue, 2018-2029 (US$, Mn)
Figure 7. Medical Erythropoietin Injection Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Medical Erythropoietin Injection Revenue in 2022
Figure 9. By Type - Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 11. By Type - Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 12. By Type - Global Medical Erythropoietin Injection Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 15. By Application - Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 16. By Application - Global Medical Erythropoietin Injection Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Medical Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Medical Erythropoietin Injection Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 20. By Region - Global Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 21. By Country - North America Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 22. By Country - North America Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 23. US Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 28. Germany Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 29. France Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 37. China Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 41. India Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 43. By Country - South America Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 44. Brazil Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Medical Erythropoietin Injection Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Medical Erythropoietin Injection Sales Market Share, 2018-2029
Figure 48. Turkey Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Medical Erythropoietin Injection Revenue, (US$, Mn), 2018-2029
Figure 52. Global Medical Erythropoietin Injection Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Medical Erythropoietin Injection by Region, 2022 VS 2029
Figure 54. Medical Erythropoietin Injection Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 遺伝子組み換えコラーゲン医療美容注射のグローバル市場展望 2023年-2029年：植物由来コラーゲン、動物由来コラーゲン
  • 注射用チオプロニンのグローバル市場展望 2023年-2029年：2ml:0.1g、5ml:0.2g
  • メトカルバモール注入のグローバル市場展望 2023年-2029年：2ml:0.2g、5ml:0.5g
  • 注射用ビアペネムのグローバル市場展望 2023年-2029年：300mg、100mg
  • 塩酸テトラカイン注射液のグローバル市場展望 2023年-2029年：25mg、50mg、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14416 )"医療用エリスロポエチン注射剤のグローバル市場展望 2023年-2029年：エポエチンアルファ、エポエチンベータ、ダルベポエチンアルファ、その他" (英文：Medical Erythropoietin Injection Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。